Clinical Trial: Role of a Mitochondrial Receptor in Blood Sugar Regulation

U.S., July 3 -- ClinicalTrials.gov registry received information related to the study (NCT07682233) titled 'Role of a Mitochondrial Receptor in Blood Sugar Regulation' on June 09.

Brief Summary: The goal of this clinical trial is to learn whether a single dose of XBD173, a medicine that binds to a protein called the 18 kiloDalton Translocator Protein (TSPO), affects how the body processes glucose in healthy volunteers aged 18 to 75 years.

The main questions it aims to answer are:

* Does a single dose of XBD173 change fasting blood glucose levels compared with placebo?

* Does a single dose of XBD173 change blood glucose levels after participants drink a glucose solution compared with placebo?

Researchers will compare XBD173 with a place...